Significantly higher levels of Ng were found in AD patients compared to patients with MCI, frontotemporal dementia (FTD), and other NDs, suggesting its role as a reliable diagnostic biomarker for the diagnosis of AD as well as for discrimination against other disorders [49]. This evidence concerns the gene NRGN and Alzheimer disease.